THE WIRE · UPDATED 8:34 AM MST No story is too small.
NewsSalt Lake City

Co-Diagnostics receives Peru test order amid rising dengue cases

Utah.News 1 source cited Details

How this story was published

Published automatically from one public source cited; not yet reviewed by the desk. Tell us if something is wrong ↗

Source

hjnews.com

Utah.News publishes every story with the sources it was built from. Questions or a correction: corrections@utah.news.

AI-written from public sources Written by Utah News AI and quality-checked before publishing.
Co-Diagnostics receives Peru test order amid rising dengue cases
Photo via Herald Journal
Co-Diagnostics announced a new order for its Logix Smart ZDC test from a distributor in Peru amid rising dengue activity. The company is also exhibiting at MEDICA 2026 in Germany and shipping tests for a study in Bolivia.

Key takeaways

  • A Peruvian distributor ordered Logix Smart ZDC tests due to rising dengue activity in Peru.
  • The company is exhibiting at MEDICA 2026 in Düsseldorf, Germany, from November 16–19.
  • Logix Smart ZDC tests were shipped to a European organization for a study in Bolivia.
  • Peru reported 83,430 dengue cases through epidemiological week 42 in 2026.

Co-Diagnostics, Inc. announced on November 17, 2026, that its distributor in Peru has placed a new order for the Logix Smart ZDC test as the country experiences a rise in dengue activity. The company is also shipping Logix Smart ZDC tests purchased by a European organization for use in a study in Bolivia.

According to the Pan American Health Organization (PAHO), Peru reported 83,430 dengue cases in 2026 through epidemiological week 42. During that week, reported cases were up 51% compared with the average of the previous four weeks.

The Logix Smart ZDC test is a real-time RT-PCR test using patented Co-Primers technology to detect and differentiate between Zika, dengue, and chikungunya viruses. While the test has held CE-IVD marking since 2019 and is available in the European Union and other markets that accept the marking, it is not available for sale in the United States.

Co-Diagnostics is exhibiting at MEDICA 2026, which is taking place November 16–19 in Düsseldorf, Germany. The company is exhibiting as part of the World Trade Center Utah booth at Stand 16E24-1 in Hall 16.

Dwight Egan, Chief Executive Officer of Co-Diagnostics, stated that new orders in South America reflect the need for a multiplex assay that differentiates Zika, dengue, and chikungunya. Egan added that the company is in Düsseldorf this week to build relationships with international customers and distributors.

In Bolivia, the Logix Smart ZDC tests were purchased by a European organization for a study conducted in collaboration with a prominent laboratory. Co-Diagnostics continues to supply real-time PCR instruments to its Bolivian distributor, having shipped approximately 17 units since the beginning of 2025.

Jonathan Freedman, President and CEO of World Trade Center Utah, stated that international trade shows like MEDICA allow companies to meet customers and partners that can drive growth. He noted that the organization helps businesses like Co-Diagnostics make connections to turn global opportunities into business results.

Co-Diagnostics is also hosting two webinars on November 17, 2026. One webinar is for potential customers of its Vector Smart mosquito surveillance solutions, and the other is through CoSara Diagnostics, a joint venture in India, regarding HPV and cervical cancer screening in recognition of World Cervical Cancer Elimination Day.

Article details

CategoryNews
CitySalt Lake City
ToneNeutral
ProductionAI Generated
Report a problem with this story
What's off? Pick any that fit, or just write below.

Every report is read and checked against the story's sources. Your email, if you give one, is used only to contact you about this message and is never shown publicly. Please keep other personal details out of the text. Privacy